| This week's sponsor is Premier Research. | | | Overcoming Risk in Oncology Drug Development
Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. Built for biotech. |
Today's Rundown Sosei Heptares pens $1B biobucks GPCR pact with Genentech On a roll, Genentech inks discovery deals with Skyhawk, Convelo Free of Pfizer, AM-Pharma raises €116M for phase 3 Trefoil Therapeutics banks $28M to create first drug for genetic eye disorder Notable Labs lands $40M to expand AI-based cancer treatment tech FDA contributes to hunt for new heart failure endpoints AI drug prospector Recursion Pharma nets $121M for its clinical programs Gilead's Kite builds cell therapy manufacturing quickly even as Yescarta sales grow slowly Featured Story | | | Tuesday, July 16, 2019 After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech. |
|
|
Top Stories Tuesday, July 16, 2019 Genentech started Tuesday with a $1 billion biobucks deal with Sosei Heptares and followed it with two more: one focused on cancer and neurodegenerative diseases with Skyhawk Therapeutics and one on neurological disorders with Convelo Therapeutics. Tuesday, July 16, 2019 AM-Pharma has raised €116 million ($131 million) to run a pivotal clinical trial in sepsis-associated acute kidney injury. The financing sets AM-Pharma up to advance independently now Pfizer has turned down its option to acquire the Dutch company. Tuesday, July 16, 2019 Trefoil Therapeutics raised $28 million to push its regenerative treatment for a group of genetic eye disorders called corneal dystrophies toward the clinic. It could replace corneal transplant as a treatment to prevent blindness in these patients. Tuesday, July 16, 2019 Notable Labs is adding $40 million to its reserves as it scales up its artificial-intelligence-based drug discovery technology with plans to take its platform worldwide. Tuesday, July 16, 2019 A collaboration involving the FDA is set to evaluate new endpoints for heart failure clinical trials. The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals. Monday, July 15, 2019 Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new financing for its artificial intelligence programs. Tuesday, July 16, 2019 So far, Gilead’s Kite Pharma has been buying the viral vector starting material for its CAR-T treatment Yescarta from contractors. But with an expanding pipeline of cell therapies, the company says it is time to be able to produce its own. | This week's sponsor is Medrio. | | | [Webinar] Accelerating Site and Patient Enrollment for Phase 1 Trials
Tuesday, July 23 | 2pm ET / 11am PT
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register Now! |
Resources Sponsored by: Reprints Desk, Inc. Cut your research time in half! Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Latin America Healthcare Compliance Certificate Program September 23-26, 2019 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 